from 30 Sep 2010 to 30 Sep 2024

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: ELITE PHARMACEUTICALS INC /NV/ quarterly Entity Public Float in USD history and change rate from 30 Sep 2010 to 30 Sep 2024.
ELITE PHARMACEUTICALS INC /NV/ Entity Public Float for the quarter ending 30 Sep 2024 was $323,296,443, a 240% increase year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$323,296,443	+$228,191,208	+240%	30 Sep 2024	10-K	30 Jun 2025	2025	FY
Q3 2023	$95,105,235	+$54,548,632	+134%	30 Sep 2023	10-K	01 Jul 2024	2024	FY
Q3 2022	$40,556,603	+$101,323	+0.25%	30 Sep 2022	10-K/A	31 Jul 2023	2023	FY
Q3 2021	$40,455,280	-$15,683,129	-28%	30 Sep 2021	10-K	29 Jun 2022	2022	FY
Q3 2020	$56,138,409	-$8,923,198	-14%	30 Sep 2020	10-K	14 Jun 2021	2021	FY
Q3 2019	$65,061,607	-$8,455,995	-12%	30 Sep 2019	10-K	29 Jun 2020	2020	FY
Q3 2018	$73,517,602	-$5,863,042	-7.4%	30 Sep 2018	10-K	21 Jun 2019	2019	FY
Q3 2017	$79,380,644	-$77,887,682	-50%	30 Sep 2017	10-K	14 Jun 2018	2018	FY
Q3 2016	$157,268,326	+$464,382	+0.3%	30 Sep 2016	10-K	14 Jun 2017	2017	FY
Q3 2015	$156,803,944	+$2,954,731	+1.9%	30 Sep 2015	10-K	15 Jun 2016	2016	FY
Q3 2014	$153,849,213	+$92,542,097	+151%	30 Sep 2014	10-K	15 Jun 2015	2015	FY
Q3 2013	$61,307,116	+$19,347,403	+46%	30 Sep 2013	10-K	30 Jun 2014	2014	FY
Q3 2012	$41,959,713			30 Sep 2012	10-K	21 Jun 2013	2012	FY
Q3 2010	$25,732,686			30 Sep 2010	10-K	29 Jun 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.